Benzinga's Top Pre-Market Gainers
MannKind (NASDAQ: MNKD) moved up 17.35% to $8.05 in the pre-market session after the company reported positive clinical data for AFREZZA.
Brocade Communications (NASDAQ: BRCD) soared 14.49% to $7.90 in the pre-market trading after the company reported better-than-expected fiscal third-quarter results.
Osiris Therapeutics (NASDAQ: OSIR) surged 9% to $27.73 in the pre-market session on clinical study results.
GenMark Diagnostics (NASDAQ: GNMK) shares gained 4.65% to $10.35 in the pre-market session after the company priced 7.6 million shares of common stock at $9.84.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.